Latest news about Cardinal Health
Here are some of the most recent media mentions. Use them in your sales prospecting to qualify a prospect's buyer intent and personalize outreach with the latest company updates
Cardinal Health reported second-quarter fiscal year 2025 revenues of $55.3 billion, a 4% decrease, but a 16% increase excluding a large customer contract expiration. Non-GAAP EPS rose to $1.93, and the company raised its fiscal year 2025 non-GAAP EPS guidance to $7.85 to $8.00. They also completed the acquisition of a majority stake in GI Alliance and Integrated Oncology Network[5].
Cardinal Health announced the start of routine production of actinium-225 (Ac-225) through its Center for Theranostics Advancement, in collaboration with TerraPower Isotopes, making it the first company to offer the isotope at commercial scale, enhancing access to theranostics and potential new cancer therapies[5].
Cardinal Health's Board of Directors approved a quarterly dividend of $0.5056 per share, payable on April 15, 2025, to shareholders of record as of April 1, 2025[3].
Open job positions at Cardinal Health
This company is actively hiring to fill these roles. Use this for sales prospecting if your solution assists, augments, or provides an alternative for the growing team and position.
Digital Marketing Production Supervisor
Sr Engineer, Application Development and Maintenance
Category Manager, U.S. Medical Products & Distribution

